Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(57.1%)

N/A

3(42.9%)

7Total

Phase 4(4)

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT00883402Not ApplicableActive Not Recruiting

Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

Role: collaborator

NCT02145338Phase 4Completed

Antibiotic Prophylaxis for Clean Intermittent Catheterisation

Role: collaborator

NCT02347033Phase 4Terminated

Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety

Role: collaborator

NCT00836459Not ApplicableCompleted

Sheffield Physical Activity Booster Trial

Role: collaborator

NCT01230580Phase 4Unknown

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Role: collaborator

NCT00514410Phase 4Completed

Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial

Role: collaborator

NCT00158106Not ApplicableCompleted

Assessing the Effectiveness of Communication Therapy in the North West (The ACT NoW Pilot Study)

Role: lead

All 7 trials loaded